SEARCH

SEARCH BY CITATION

References

  • Armbruster, C., Stiegler, G.M., Vcelar, B.A., Jager, W., Michael, N.L., Vetter, N. and Katinger, H.W.D. (2002) A phase I trial with two human monoclonal antibodies (hMAb 2F5, 2G12) against HIV-1. Aids, 16, 227233.
  • Armbruster, C., Stiegler, G.M., Vcelar, B.A., Jager, W., Koller, U., Jilch, R., Ammann, C.G., Pruenster, M., Stoiber, H. and Katinger, H.W.D. (2004) Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12. J. Antimicrob. Chemother. 54, 915920.
  • Artsaenko, O., Peisker, M., Zur Nieden, U., Fiedler, U., Weiler, E.W., Muntz, K. and Conrad, U. (1995) Expression of a single-chain Fv antibody against abscisic-acid creates a wilty phenotype in transgenic tobacco. Plant J. 8, 745750.
  • Baba, T.W., Liska, V., Hofmann-Lehmann, R., Vlasak, J., Xu, W.D., Ayehunie, S., Cavacini, L.A., Posner, M.R., Katinger, H., Stiegler, G., Bernacky, B.J., Rizvi, T.A., Schmidt, R., Hill, L.R., Keeling, M.E., Lu, Y.C., Wright, J.E., Chou, T.C. and Ruprecht, R.M. (2000) Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6, 200206.
  • Binley, J.A., Wrin, T., Korber, B., Zwick, M.B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., Petropoulos, C.J. and Burton, D.R. (2004) Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78, 13 23213 252.
  • Carter, P.J. (2006) Potent antibody therapeutics by design. Nat. Rev. Immunol. 6, 343357.
  • Check, E. (2003) Aids vaccines: Back to ‘plan A’. Nature, 423, 912914.
  • Chilkoti, A., Christensen, T. and Mackay, J.A. (2006) Stimulus responsive elastin biopolymers: applications in medicine and biotechnology. Curr. Opin. Chem. Biol. 10, 652657.
  • Deblaere, R., Bytebier, B., Degreve, H., Deboeck, F., Schell, J., Van Montagu, M. and Leemans, J. (1985) Efficient octopine Ti plasmid-derived vectors for Agrobacterium-mediated gene transfer to plants. Nucleic Acids Res. 13, 47774788.
  • Fischer, R., Stoger, E., Schillberg, S., Christou, P. and Twyman, R.M. (2004) Plant-based production of biopharmaceuticals. Curr. Opin. Plant Biol. 7, 152158.
  • Floss, D.M., Falkenburg, D. and Conrad, U. (2007) Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic Res. 16, 315332.
  • Ge, X., Trabbic-Carlson, K., Chilkoti, A. and Filipe, C.D.M. (2006) Purification of an elastin-like fusion protein by microfiltration. Biotechnol. Bioeng. 95, 424432.
  • Gil, F., Titarenko, E., Terrada, E., Arcalis, E. and Escribano, J.M. (2006) Successful oral prime-immunization with VP60 from rabbit haemorrhagic disease virus produced in transgenic plants using different fusion strategies. Plant Biotechnol. J. 4, 135143.
  • Kapila, J., DeRycke, R., Van Montagu, M. and Angenon, G. (1997) An Agrobacterium-mediated transient gene expression system for intact leaves. Plant Sci. 122, 101108.
  • Ko, K. and Koprowski, H. (2005) Plant biopharming of monoclonal antibodies. Virus Res. 111, 93100.
  • Ko, K., Tekoah, Y., Rudd, P.M., Harvey, D.J., Dwek, R.A., Spitsin, S., Hanlon, C.A., Rupprecht, C., Dietzschold, B., Golovkin, M. and Koprowski, H. (2003) Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc. Natl. Acad. Sci. USA, 100, 80138018.
  • Kolarich, D. and Altmann, F. (2000) N-glycan analysis by matrix-assisted laser desorption/ionization mass spectrometry of electrophoretically separated nonmammalian proteins: application to peanut allergen Ara h 1 and olive pollen allergen Ole e 1. Anal. Biochem. 285, 6475.
  • Kolarich, D., Altmann, F. and Sunderasan, E. (2006) Structural analysis of the glycoprotein allergen Hev b 4 from natural rubber latex by mass spectrometry. Biochim. Biophys. Acta, 1760, 715720.
  • Law, R.D., Russell, D.A., Thompson, L.C., Schroeder, S.C., Middle, C.M., Tremaine, M.T., Jury, T.P., Delannay, X. and Slater, S.C. (2006) Biochemical limitations to high-level expression of humanized monoclonal antibodies in transgenic maize seed endosperm. Biochim. Biophys. Acta, 1760, 14341444.
  • Li, B. and Daggett, V. (2002) Molecular basis for the extensibility of elastin. J. Muscle Res. Cell Motil. 23, 561573.
  • Li, B. and Daggett, V. (2003) The molecular basis of the temperature- and pH-induced conformational transitions in elastin-based peptides. Biopolymers, 68, 121129.
  • Li, B., Alonso, D.O. and Daggett, V. (2001) The molecular basis for the inverse temperature transition of elastin. J. Mol. Biol. 305, 581592.
  • Lin, M., Rose-John, S., Grotzinger, J., Conrad, U. and Scheller, J. (2006) Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: purification via inverse transition cycling. Biochem. J. 398, 577583.
  • Ma, J.K., Drake, P.M. and Christou, P. (2003) The production of recombinant pharmaceutical proteins in plants. Nat. Rev. Genet. 4, 794805.
  • Ma, J.K.C., Drake, P.M.W., Chargelegue, D., Obregon, P. and Prada, A. (2005) Antibody processing and engineering in plants, and new strategies for vaccine production. Vaccine, 23, 18141818.
  • Mascola, J.R., Lewis, M.G., Stiegler, G., Harris, D., VanCott, T.C., Hayes, D., Louder, M.K., Brown, C.R., Sapan, C.V., Frankel, S.S., Lu, Y.C., Robb, M.L., Katinger, H. and Birx, D.L. (1999) Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol. 73, 40094018.
  • Mascola, J.R., Stiegler, G., VanCott, T.C., Katinger, H., Carpenter, C.B., Hanson, C.E., Beary, H., Hayes, D., Frankel, S.S., Birx, D.L. and Lewis, M.G. (2000) Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6, 207210.
  • McGowan, I. (2006) Microbicides: a new frontier in HIV prevention. Biologicals, 34, 241255.
  • Mehandru, S., Wrin, T., Galovich, J., Stiegler, G., Vcelar, B., Hurley, A., Hogan, C., Vasan, S., Katinger, H., Petropoulos, C.J. and Markowitz, M. (2004) Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10. J. Virol. 78, 14 03914 042.
  • Meyer, D.E. and Chilkoti, A. (1999) Purification of recombinant proteins by fusion with thermally-responsive polypeptides. Nat. Biotechnol. 17, 11121115.
  • Obregon, P., Chargelegue, D., Drake, P.M.W., Prada, A., Nuttall, J., Frigerio, L. and Ma, J.K.C. (2006) HIV-1 p24-immunoglobulin fusion molecule: a new strategy for plant-based protein production. Plant Biotechnol. J. 4, 195207.
  • Patel, J., Zhu, H., Menassa, R., Gyenis, L., Richman, A. and Brandle, J. (2007) Elastin-like polypeptide fusions enhance the accumulation of recombinant proteins in tobacco leaves. Transgenic Res. 16, 239249.
  • Peterson, E., Owens, S.M. and Henry, R.L. (2006) Monoclonal antibody form and function: manufacturing the right antibodies for treating drug abuse. AAPS J. 8, E383E390.
  • Petruccelli, S., Otegui, M.S., Lareu, F., Tran, D.O., Fitchette, A.C., Circosta, A., Rumbo, M., Bardor, M., Carcamo, R., Gomord, V. and Beachy, R.N. (2006) A KDEL-tagged monoclonal antibody is efficiently retained in the endoplasmic reticulum in leaves, but is both partially secreted and sorted to protein storage vacuoles in seeds. Plant Biotechnol. J. 4, 511527.
  • Purtscher, M., Trkola, A., Gruber, G., Buchacher, A., Predl, R., Steindl, F., Tauer, C., Berger, R., Barrett, N. and Jungbauer, A. (1994) A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses, 10, 16511658.
  • Reichert, J.M. and Valge-Archer, V.E. (2007) Development trends for monoclonal antibody cancer therapeutics. Nat. Rev. Drug Discov. 6, 349356.
  • Sack, M., Paetz, A., Kunert, R., Bomble, M., Hesse, F., Stiegler, G., Fischer, R., Katinger, H., Stoeger, E. and Rademacher, T. (2007) Functional analysis of the broadly neutralizing human anti-HIV-1 antibody 2F5 produced in transgenic BY-2 suspension cultures. FASEB J. 21, 16551664.
  • Saketkoo, L.A. and Espinoza, L.R. (2006) Impact of biologic agents on infectious diseases. Infect. Dis. Clin. North Am. 20, 931961.
  • Scheller, J., Henggeler, D., Viviani, A. and Conrad, U. (2004) Purification of spider silk-elastin from transgenic plants and application for human chondrocyte proliferation. Transgenic Res. 13, 5157.
  • Scheller, J., Leps, M. and Conrad, U. (2006) Forcing single-chain variable fragment production in tobacco seeds by fusion to elastin-like polypeptides. Plant Biotechnol. J. 4, 243249.
  • Shimazu, M., Mulchandani, A. and Chen, W. (2003) Thermally triggered purification and immobilization of elastin-OPH fusions. Biotechnol. Bioeng. 81, 7479.
  • Simnick, A.J., Lim, D.W., Chow, D. and Chilkoti, A. (2007) Biomedical and biotechnological applications of elastin-like polypeptides. Polymer Rev. 47, 121154.
  • Sriraman, R., Bardor, M., Sack, M., Vaquero, C., Faye, L., Fischer, R., Finnern, R. and Lerouge, P. (2004) Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-alpha(1,3)-fucose residues. Plant Biotechnol. J. 2, 279287.
  • Stoger, E., Ma, J.K.C., Fischer, R. and Christou, P. (2005a) Sowing the seeds of success: pharmaceutical proteins from plants. Curr. Opin. Biotechnol. 16, 167173.
  • Stoger, E., Sack, M., Nicholson, L., Fischer, R. and Christou, P. (2005b) Recent progress in plantibody technology. Curr. Pharm. Des. 11, 24392457.
  • Tekoah, Y., Ko, K., Koprowski, H., Harvey, D.J., Wormald, M.R., Dwek, R.A. and Rudd, P.M. (2004) Controlled glycosylation of therapeutic antibodies in plants. Arch. Biochem. Biophys. 426, 266278.
  • Triguero, A., Cabrera, G., Cremata, J.A., Yuen, C.T., Wheeler, J. and Ramirez, N.I. (2005) Plant-derived mouse IgG monoclonal antibody fused to KDEL endoplasmic reticulum-retention signal is N-glycosylated homogeneously throughout the plant with mostly high-mannose-type N-glycans. Plant Biotechnol. J. 3, 449457.
  • Urry, D.W., Parker, T.M., Reid, M.C. and Gowda, D.C. (1991) Biocompatibility of the bioelastic materials, poly(GVGVP) and its gamma-irradiation cross-linked matrix – summary of generic biological test results. J. Bioact. Compat. Polym. 6, 263282.
  • Van Droogenbroeck, B., Cao, J.Y., Stadlmann, J., Altmann, F., Colanesi, S., Hillmer, S., Robinson, D.G., Van Lerberge, E., Terryn, N., Van Montagu, M., Liang, M.F., Depicker, A. and De Jaeger, G. (2007) Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds. Proc. Natl. Acad. Sci. USA, 104, 14301435.
  • Vaquero, C., Sack, M., Chandler, J., Drossard, J., Schuster, F., Monecke, M., Schillberg, S. and Fischer, R. (1999) Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves. Proc. Natl. Acad. Sci. USA, 96, 11 12811 133.
  • Walsh, G. and Jefferis, R. (2006) Post-translational modifications in the context of therapeutic proteins. Nat. Biotechnol. 24, 12411252.
  • Weber, J., Desai, K. and Darbyshire, J. (2005) The development of vaginal microbicides for the prevention of HIV transmission. PLoS Med. 2, e142.
  • Xiang, C.B., Han, P., Lutziger, I., Wang, K. and Oliver, D.J. (1999) A mini binary vector series for plant transformation. Plant Mol. Biol. 40, 711717.
  • Zambrinski, P., Joos, H., Gentello, J., Leemans, J., Van Montagu, M. and Schell, J. (1983) Ti-plasmid vector for introduction of DNA into plant cells without altering their normal regeneration capacity. EMBO J. 2, 21112123.
  • Zeitlin, L., Olmsted, S.S., Moench, T.R., Co, M.S., Martinell, B.J., Paradkar, V.M., Russell, D.R., Queen, C., Cone, R.A. and Whaley, K.J. (1998) A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat. Biotechnol. 16, 13611364.